IBEX (IBEX) Competitors $29.10 +0.60 (+2.11%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IBEX vs. NVEE, VVX, GB, TASK, OLO, UPBD, FLYW, ASTH, CRTO, and EVHShould you be buying IBEX stock or one of its competitors? The main competitors of IBEX include NV5 Global (NVEE), V2X (VVX), Global Blue Group (GB), TaskUs (TASK), OLO (OLO), Upbound Group (UPBD), Flywire (FLYW), Astrana Health (ASTH), Criteo (CRTO), and Evolent Health (EVH). These companies are all part of the "business services" industry. IBEX vs. Its Competitors NV5 Global V2X Global Blue Group TaskUs OLO Upbound Group Flywire Astrana Health Criteo Evolent Health NV5 Global (NASDAQ:NVEE) and IBEX (NASDAQ:IBEX) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Does the media favor NVEE or IBEX? In the previous week, NV5 Global and NV5 Global both had 6 articles in the media. NV5 Global's average media sentiment score of 0.58 beat IBEX's score of 0.07 indicating that NV5 Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NV5 Global 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IBEX 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, NVEE or IBEX? NV5 Global has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, IBEX has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Do insiders and institutionals believe in NVEE or IBEX? 75.5% of NV5 Global shares are owned by institutional investors. Comparatively, 81.2% of IBEX shares are owned by institutional investors. 12.4% of NV5 Global shares are owned by company insiders. Comparatively, 6.7% of IBEX shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, NVEE or IBEX? IBEX has lower revenue, but higher earnings than NV5 Global. IBEX is trading at a lower price-to-earnings ratio than NV5 Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNV5 Global$941.27M1.64$27.98M$0.5046.18IBEX$508.57M0.77$33.65M$2.2912.71 Do analysts prefer NVEE or IBEX? NV5 Global presently has a consensus price target of $25.67, indicating a potential upside of 11.16%. IBEX has a consensus price target of $27.00, indicating a potential downside of 7.22%. Given NV5 Global's stronger consensus rating and higher probable upside, equities research analysts plainly believe NV5 Global is more favorable than IBEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NV5 Global 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29IBEX 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is NVEE or IBEX more profitable? IBEX has a net margin of 6.93% compared to NV5 Global's net margin of 3.19%. IBEX's return on equity of 25.51% beat NV5 Global's return on equity.Company Net Margins Return on Equity Return on Assets NV5 Global3.19% 9.12% 5.84% IBEX 6.93%25.51%12.67% SummaryNV5 Global beats IBEX on 9 of the 15 factors compared between the two stocks. Get IBEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IBEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IBEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IBEX vs. The Competition Export to ExcelMetricIBEXBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$381.11M$6.00B$13.00B$8.90BDividend YieldN/A3.08%2.60%4.13%P/E Ratio12.7121.7728.1719.67Price / Sales0.771.9739.67110.29Price / Cash8.9213.6224.0427.49Price / Book3.025.246.265.42Net Income$33.65M$150.49M$188.17M$248.34M7 Day Performance2.18%0.22%1.07%0.81%1 Month Performance1.39%1.77%3.49%5.01%1 Year Performance82.33%64.60%25.68%18.10% IBEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IBEXIBEX1.0871 of 5 stars$29.10+2.1%$27.00-7.2%+79.9%$381.11M$508.57M12.7130,000NVEENV5 Global2.1713 of 5 stars$23.09+1.3%$25.67+11.2%-0.7%$1.55B$941.27M46.655,024VVXV2X4.0118 of 5 stars$48.61+0.6%$62.80+29.2%+1.4%$1.54B$4.32B37.6816,100GBGlobal Blue Group2.4476 of 5 stars$7.47-0.1%$6.00-19.7%+55.0%$1.49B$545.29M20.192,160TASKTaskUs1.4135 of 5 stars$16.76flat$17.67+5.4%+25.9%$1.49B$994.98M27.4848,200Positive NewsOLOOLO1.3068 of 5 stars$8.96+3.9%$9.00+0.4%+102.7%$1.49B$284.94M448.22710News CoverageHigh Trading VolumeUPBDUpbound Group4.5403 of 5 stars$25.10-1.5%$34.50+37.5%-18.2%$1.45B$4.32B11.7811,970Positive NewsFLYWFlywire4.2263 of 5 stars$11.70+2.5%$15.00+28.2%-28.6%$1.42B$492.14M292.501,250ASTHAstrana Health2.7276 of 5 stars$24.88+0.6%$53.29+114.2%-38.7%$1.39B$2.25B34.561,900CRTOCriteo4.1494 of 5 stars$23.96+0.5%$46.70+94.9%-36.5%$1.39B$1.93B9.743,507EVHEvolent Health1.7006 of 5 stars$11.31+1.3%$17.79+57.3%-40.8%$1.33B$2.55B-9.204,500 Related Companies and Tools Related Companies NVEE Competitors VVX Competitors GB Competitors TASK Competitors OLO Competitors UPBD Competitors FLYW Competitors ASTH Competitors CRTO Competitors EVH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IBEX) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.